Mayu Health Care
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Mayuglim 3D 1mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Mayuglim 3D 1mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mayuglim 3D 1mg/500mg/0.3mg Tablet is to be taken empty stomach.
Mayuglim 3D 1mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Mayuglim 3D 1mg/500mg/0.3mg Tablet contains three medications: Glimepiride, Metformin and Voglibose. This medication is used for the treatment of type 2 diabetes mellitus (DM). It helps improve blood glucose levels in adults when taken with a balanced diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels. This combination is not indicated for Type 1 DM treatment.
Common side effects may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid this medication if you have allergies to any component or excipient, are experiencing moderate to severe kidney disease, or have inflammatory bowel diseases such as ulcerative colitis, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, it is not safe to combine alcohol with Mayuglim 3D 1mg/500mg/0.3mg Tablet, as it can lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Mayuglim 3D 1mg/500mg/0.3mg Tablet may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely when you miss meals, drink alcohol, exercise intensely, or take other antidiabetic medications with it. Regular monitoring of blood glucose levels is necessary.
Store this medication in its original packaging, tightly sealed, and according to the label's instructions. Dispose of unused medication properly, making sure it is inaccessible to pets, children, and others.